Literature DB >> 17900210

The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report.

Michael D Turner1, Vasiliki Karlis, Robert S Glickman.   

Abstract

Dapsone is a leprostatic agent commonly prescribed for the management of leprosy, malaria, and the immunosuppression-induced infections of Pneumocystis carinii and Toxoplasma gondii. In susceptible patients, methemoglobinemia, a potentially life-threatening event, can occur. We report a case of dapsone-induced methemoglobinemia which was observed during general anesthesia for the management of a fractured mandible. The pathophysiology, diagnosis, and management of dapsone-induced methemoglobinemia will be discussed.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17900210      PMCID： PMC1993865          DOI： 10.2344/0003-3006(2007)54[115:TRPATO]2.0.CO;2

Source DB:  PubMed          Journal:  Anesth Prog        ISSN： 0003-3006


  10 in total

1.  Generalised deficiency of cytochrome b5 reductase in congenital methaemoglobinaemia with mental retardation.

Authors:  A Leroux; C Junien; J Kaplan; J Bamberger
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

Review 2.  Dapsone toxicity: some current perspectives.

Authors:  M D Coleman
Journal:  Gen Pharmacol       Date:  1995-11

3.  The reduction of methaemoglobin in red blood cells and studies on the cause of idiopathic methaemoglobinaemia.

Authors:  Q H Gibson
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

4.  1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.

Authors: 
Journal:  Clin Infect Dis       Date:  1997-10       Impact factor: 9.079

5.  Dapsone induced methaemoglobinaemia.

Authors:  D Landers; C Bergin; A O'Leary; C Merry; S Keating; F Mulcahy
Journal:  Int J STD AIDS       Date:  1996-10       Impact factor: 1.359

6.  Effects of methemoglobinemia on pulse oximetry and mixed venous oximetry.

Authors:  S J Barker; K K Tremper; J Hyatt
Journal:  Anesthesiology       Date:  1989-01       Impact factor: 7.892

Review 7.  Dapsone-induced methemoglobinemia.

Authors:  K E Ward; M W McCarthy
Journal:  Ann Pharmacother       Date:  1998-05       Impact factor: 3.154

Review 8.  Methemoglobinemia induced by topical anesthesia: a case report and review.

Authors:  N A Khan; J A Kruse
Journal:  Am J Med Sci       Date:  1999-12       Impact factor: 2.378

9.  Methemoglobinemia.

Authors:  S Curry
Journal:  Ann Emerg Med       Date:  1982-04       Impact factor: 5.721

Review 10.  Drug- and chemical-induced methaemoglobinaemia. Clinical features and management.

Authors:  A H Hall; K W Kulig; B H Rumack
Journal:  Med Toxicol       Date:  1986 Jul-Aug
  10 in total
  10 in total

1.  Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: methemoglobinemia following dapsone exposure.

Authors:  Joshua Canning; Michael Levine
Journal:  J Med Toxicol       Date:  2011-06

2.  Very late relapse of dapsone-induced methaemoglobinemia.

Authors:  Guillaume Moulis; Haleh Bagheri; Jacques Saint Martory; Pascale Bernard; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2010-03-13       Impact factor: 2.953

3.  Methemoglobinemia: A Girl with 'Chocolate Brown' Colored Blood.

Authors:  Manas Kumar Mahapatra; Prabhas Prasun Giri
Journal:  Indian J Pediatr       Date:  2018-05-18       Impact factor: 1.967

4.  Acute dapsone poisoning in a 3-year-old child: Case report with review of literature.

Authors:  Menon Narayanankutty Sunilkumar; Thekkuttuparambil Ananthanarayanan Ajith; Vadakut Krishnan Parvathy
Journal:  World J Clin Cases       Date:  2015-10-16       Impact factor: 1.337

5.  Dapsone-associated methemoglobinemia in a patient with slow NAT2*5B haplotype and impaired cytochrome b5 reductase activity.

Authors:  Mahmoud Abouraya; James C Sacco; Kristie Hayes; Sajeve Thomas; Craig S Kitchens; Lauren A Trepanier
Journal:  J Clin Pharmacol       Date:  2012-02       Impact factor: 3.126

6.  Dapsone induced methemoglobinemia in a patient with glioblastoma.

Authors:  Julie G Walker; Tapan Kadia; Latrondria Brown; Harinder S Juneja; John F de Groot
Journal:  J Neurooncol       Date:  2009-02-14       Impact factor: 4.130

7.  Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats.

Authors:  Changwoo Kang; Dong Hoon Kim; Taeyun Kim; Soo Hoon Lee; Jin Hee Jeong; Sang Bong Lee; Jin Hyun Kim; Myeong Hee Jung; Kyung-Woo Lee; In Sung Park
Journal:  Clin Exp Emerg Med       Date:  2018-09-30

8.  The mystery of 'saturation gap': a case of dapsone-induced methaemoglobinemia in a pregnant mother with leprosy.

Authors:  Andy Sing Ong Tang; Siaw Tze Yeo; Yeon Chiat Teh; Wee Meng Kho; Lee Ping Chew; Pubalan Muniandy
Journal:  Oxf Med Case Reports       Date:  2019-01-24

9.  Refractory Methemoglobinemia Secondary to Topical Dapsone With Subsequent Autoimmune Hemolytic Anemia.

Authors:  Catharine Cantrell; Vincent Costers; Chandler C Wilson; Christopher J Dudek; Justin K Arnold
Journal:  Cureus       Date:  2022-09-05

10.  Methemoglobinemia in a Pediatric Oncology Patient Receiving Sulfamethoxazole/Trimethoprim Prophylaxis.

Authors:  Timothy G Carroll; Megan G Carroll
Journal:  Am J Case Rep       Date:  2016-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.